The pharmacological treatment of nystagmus: A review

Expert Opinion on Pharmacotherapy

Volumn 10, Issue 11, 2009, Pages 1805-1816

  McLean, Rebecca Jane ^a   Gottlob, Irene ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

3,4 diaminopyridine; Acquired nystagmus; Acquired pendular nystagmus; Baclofen; Downbeat nystagmus; Gabapentin; Infantile nystagmus; Memantine; Multiple sclerosis; Periodic alternating nystagmus; Upbeat nystagmus

Indexed keywords

3,4 DIAMINOPYRIDINE; 4 AMINOPYRIDINE; 5 HYDROXYTRYPTOPHAN; AMINOPYRIDINE; BACLOFEN; BENSERAZIDE; BOTULINUM TOXIN; CARBAMAZEPINE; CLONAZEPAM; DIAZEPAM; GABAPENTIN; ISONIAZID; MEMANTINE; SCOPOLAMINE; THIOCOLCHICOSIDE; TRIHEXYPHENIDYL; VIGABATRIN;

ACQUIRED PENDULAR NYSTAGMUS; DRUG EFFECT; EYE MOVEMENT; EYE SURGERY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEADACHE; HUMAN; NAUSEA; NONHUMAN; NYSTAGMUS; OSCILLOPSIA; PET ANIMAL; REVIEW; VISUAL ACUITY;

AMINES; ANIMALS; BACLOFEN; CYCLOHEXANECARBOXYLIC ACIDS; GAMMA-AMINOBUTYRIC ACID; HUMANS; MEMANTINE; NYSTAGMUS, CONGENITAL; NYSTAGMUS, PATHOLOGIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 68149181541     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656560902978446     Document Type: Review

References (90)

1. Gottlob I. Nystagmus. Curr Opin Ophthalmol 2001;12(5):378-383
2. Stahl J, Plant G, Leigh R. Medical treatment of nystagmus and its visual consequences. J R Soc Med 2002;95:235-237 (Pubitemid 34533785)
3. Curcio CA, Sloan KR, Kalina RE, Hendrickson AE. Human photoreceptor topography. J Comp Neurol 1990;292(4):497-523
4. Chung ST, Bedell HE. Velocity criteria for "foveation periods" determined from image motions simulating congenital nystagmus. Optom Vis Sci 1996;73(2):92-103
5. Leigh RJ, Zee DS. The neurology of eye movements. 4th edition. Oxford: Oxford University Press; 2006 •• Provides a comprehensive synthesis of the physiology and pathology of eye movements.
6. Choudhuri I, Sarvananthan N, Gottlob I. Survey of management of acquired nystagmus in the United Kingdom. Eye 2007;21(9):1194-1197 (Pubitemid 47382146)
7. Abadi RV, Bjerre A. Motor and sensory characteristics of infantile nystagmus. Br J Ophthalmol 2002;86(10):1152-1160
8. van der Geest JN, Frens MA. Recording eye movements with video-oculography and scleral search coils: a direct comparison of two methods. J Neurosci Methods 2002;114(2):185-195
9. Roberti G, Russo P, Segre G. Spectral analysis of electro-oculograms in the quantitative evaluation of nystagmus surgery. Med Biol Eng Comput 1987;25(5):573-576 (Pubitemid 17651683)
10. Abadi RV, Whittle J. The nature of head postures in congenital nystagmus. Arch Ophthalmol 1991;109(2):216-220
11. Pilling RF, Thompson JR, Gottlob I. Social and visual function in nystagmus. Br J Ophthalmol 2005;89(10):1278-1281
12. Stayte M, Reeves B, Wortham C. Ocular and vision defects in preschool children. Br J Ophthalmol 1993;77(4):228-232 (Pubitemid 23133034)
13. Sarvananthan N, Surendran M, Roberts E et al. The Prevalence of Nystagmus: The Leicestershire Nystagmus Survey. IOVS (In Press)
14. Leigh RJ, Das VE, Seidman SH. A neurobiological approach to acquired nystagmus. Ann NY Acad Sci 2002;956:380-390
15. Bronstein AM. Vision and vertigo: some visual aspects of vestibular disorders. J Neurol 2004;251(4):381-387
16. Averbuch-Heller L, Leigh RJ. Medical treatments for abnormal eye movements: pharmacological, optical and immunological strategies. Aust NZ J Ophthalmol 1997;25(1):7-13 (Pubitemid 27219743)
17. Das VE, Oruganti P, Kramer PD, Leigh RJ. Experimental tests of a neural-network model for ocular oscillations caused by disease of central myelin. Exp Brain Res 2000;133(2):189-197 (Pubitemid 30449904)
18. Buttner-Ennever JA, Horn AK. Pathways from cell groups of the paramedian tracts to the floccular region. Ann NY Acad Sci 1996;781:532-540
19. Lopez LI, Bronstein AM, Gresty MA, et al. Clinical and MRI correlates in 27 patients with acquired pendular nystagmus. Brain 1996;119(Pt 2):465-472
20. Arnold DB, Robinson DA, Leigh RJ. Nystagmus induced by pharmacological inactivation of the brainstem ocular motor integrator in monkey. Vis Res 1999;39(25):4286-4295 • An animal study showing that microinjections of agents with agonist or antagonist actions at GABA, glutamate and kainate receptors all cause gaze-evoked nystagmus.
21. Straube A, Kurzan R, Buttner U. Differential effects of bicuculline and muscimol microinjections into the vestibular nuclei on simian eye movements. Exp Brain Res 1991;86(2):347-358
22. Ruigrok TJ, de Zeeuw CI, Voogd J. Hypertrophy of inferior olivary neurons: a degenerative, regenerative or plasticity phenomenon. Eur J Morphol 1990;28(2-4):224-239 (Pubitemid 20333242)
23. Jabbari B, Rosenberg M, Scherokman B, et al. Effectiveness of trihexyphenidyl against pendular nystagmus and palatal myoclonus: evidence of cholinergic dysfunction. Mov Disord 1987;2(2):93-98
24. Herishanu Y, Louzoun Z. Trihexyphenidyl treatment of vertical pendular nystagmus. Neurology 1986;36(1):82-84 (Pubitemid 16186055)
25. Leigh RJ, Burnstine TH, Ruff RL, Kasmer RJ. Effect of anticholinergic agents upon acquired nystagmus: a double-blind study of trihexyphenidyl and tridihexethyl chloride. Neurology 1991;41(11):1737-1741
26. Barton JJ, Huaman AG, Sharpe JA. Muscarinic antagonists in the treatment of acquired pendular and downbeat nystagmus: a double-blind, randomized trial of three intravenous drugs. Ann Neurol 1994;35(3):319-325
27. Traccis S, Rosati G, Monaco MF, et al. Successful treatment of acquired pendular elliptical nystagmus in multiple sclerosis with isoniazid and base-out prisms. Neurology 1990;40(3 Pt 1):492-494 (Pubitemid 20117536)
28. Schon F, Hart PE, Hodgson TL, et al. Suppression of pendular nystagmus by smoking cannabis in a patient with multiple sclerosis.[see comment]. Neurology 1999;53(9):2209-2210
29. Averbuch-Heller L, Tusa RJ, Fuhry L, et al. A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus. Ann Neurol 1997;41(6):818-825 •• One of the few clinical trials showing the efficacy of gabapentin in acquired nystagmus. (Pubitemid 27249189)
30. Stahl JS, Rottach KG, Averbuch-Heller L, et al. A pilot study of gabapentin as treatment for acquired nystagmus. Neuro Ophthalmol 1996;16(2):107-113 (Pubitemid 26124684)
31. Fabre K, Smet-Dieleman H, Zeyen T. Improvement of acquired pendular nystagmus by gabapentin: case report. Bull Soc Belge Ophtalmol 2001;(282):43-46
32. Bandini F, Castello E, Mazzella L, et al. Gabapentin but not vigabatrin is effective in the treatment of acquired nystagmus in multiple sclerosis: How valid is the GABAergic hypothesis? J Neurol Neurosurg Psychiatry 2001;71(1):107-110 • A small trial that highlights the usefulness of gabapentin, but not vigabatrin, in acquired nystagmus, suggesting that the success of gabapentin may be due to its additional non-GABAergic properties.
33. Starck M, Albrecht H, Pollmann W, et al. Drug therapy for acquired pendular nystagmus in multiple sclerosis. J Neurol 1997;244(1):9-16 • An early report that shows the positive effects of memantine on acquired pendular nystagmus in multiple sclerosis. (Pubitemid 26413892)
34. Wagner JN, Glaser M, Brandt T, Strupp M. Downbeat nystagmus: aetiology and comorbidity in 117 patients. J Neurol Neurosurg Psychiatry 2008;79(6):672-677 (Pubitemid 351829440)
35. Stone LS, Lisberger SG. Visual responses of Purkinje cells in the cerebellar flocculus during smooth-pursuit eye movements in monkeys. II. Complex spikes. J Neurophysiol 1990;63(5):1262-1275 (Pubitemid 20188884)
36. Zee DS, Yamazaki A, Butler PH, Gucer G. Effects of ablation of flocculus and paraflocculus of eye movements in primate. J Neurophysiol 1981;46(4):878-899 (Pubitemid 11022554)
37. Dieterich M, Brandt T. Functional brain imaging of peripheral and central vestibular disorders. Brain 2008;131(Pt 10):2538-2552 • A review that summarizes current knowledge of vestibular structures and functions from brain activation studies with PET and MRI.
38. Bense S, Best C, Buchholz HG, et al. 18F-fluorodeoxyglucose hypometabolism in cerebellar tonsil and flocculus in downbeat nystagmus. Neuroreport 2006;17(6):599-603
39. Kalla R, Deutschlander A, Hufner K, et al. Detection of floccular hypometabolism in downbeat nystagmus by fMRI. Neurology 2006;66(2):281-283 (Pubitemid 43970177)
40. Marti S, Straumann D, Buttner U, Glasauer S. A model-based theory on the origin of downbeat nystagmus. Exp Brain Res 2008;188(4):613-631 • A recent paper that illustrates how a model simulation of the effect of the loss of Purkinje cells results in features commonly associated with downbeat nystagmus.
41. Currie JN, Matsuo V. The use of clonazepam in the treatment of nystagmus-induced oscillopsia. Ophthalmology 1986;93(7):924-932 (Pubitemid 16046102)
42. Young YH, Huang TW. Role of clonazepam in the treatment of idiopathic downbeat nystagmus. Laryngoscope 2001;111(8):1490-1493 (Pubitemid 32730200)
43. Dieterich M, Straube A, Brandt T, et al. The effects of baclofen and cholinergic drugs on upbeat and downbeat nystagmus. J Neurol Neurosurg Psychiatry 1991;54(7):627-632
44. Strupp M, Schuler O, Krafczyk S, et al. Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study.[see comment]. Neurology 2003;61(2):165-170 •• The first placebo-controlled trial highlighting the positive effects of potassium-channel blockers on downbeat nystagmus.
45. Pierrot-Deseilligny C, Milea D. Vertical nystagmus: clinical facts and hypotheses. Brain 2005;128(Pt 6):1237-1246 •• A recent interesting review article covering the hypotheses for vertical nystagmus. (Pubitemid 40826178)
46. Ito M, Nisimaru N, Yamamoto M. Specific patterns of neuronal connexions involved in the control of the rabbit's vestibulo-ocular reflexes by the cerebellar flocculus. J Physiol 1977;265(3):833-854 (Pubitemid 8056787)
47. Leigh RJ. Potassium channels, the cerebellum, and treatment for downbeat nystagmus.[comment]. Neurology 2003;61(2):158-159
48. Strupp M, Kalla R, Glasauer S, et al. Aminopyridines for the treatment of cerebellar and ocular motor disorders. Prog Brain Res 2008;171:535-541
49. Kalla R, Glasauer S, Buttner U, et al. 4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus. Brain 2007;130(Pt 9):2441-2451 • A clinical trial proposing that 4-aminopyridine may be a treatment option for downbeat nystagmus regardless of the aetiology. (Pubitemid 47327634)
50. Lee AG, Brazis PW. Localizing forms of nystagmus: symptoms, diagnosis, and treatment. Curr Neurol Neurosci Rep 2006;6(5):414-420 (Pubitemid 44445685)
51. Iwata A, Takao F, Kunimoto M, Inoue K. Primary position upbeat nystagmus reversed with carbamazepine. Eur J Neurol 1996;3:260-263 (Pubitemid 26184309)
52. Glasauer S, Kalla R, Buttner U, et al. 4-aminopyridine restores visual ocular motor function in upbeat nystagmus. J Neurol Neurosurg Psychiatry 2005;76(3):451-453 (Pubitemid 40299147)
53. Waespe W, Cohen B, Raphan T. Dynamic modification of the vestibulo-ocular reflex by the nodulus and uvula. Science 1985;228(4696):199-202 (Pubitemid 15117277)
54. Cohen B, Henn V, Raphan T, Dennett D. Velocity storage, nystagmus, and visual-vestibular interactions in humans. Ann NY Acad Sci 1981;374:421-433 (Pubitemid 12214072)
55. Leigh RJ, Robinson DA, Zee DS. A hypothetical explanation for periodic alternating nystagmus: instability in the optokinetic-vestibular system. Ann NY Acad Sci 1981;374:619-635
56. Cohen B, Helwig D, Raphan T. Baclofen and velocity storage: a model of the effects of the drug on the vestibulo-ocular reflex in the rhesus monkey. J Physiol 1987;393:703-725 (Pubitemid 18046972)
57. Halmagyi GM, Rudge P, Gresty MA, et al. Treatment of periodic alternating nystagmus. Ann Neurol 1980;8(6):609-611
58. Nuti D, Ciacci G, Giannini F, et al. Aperiodic alternating nystagmus: report of two cases and treatment by baclofen. Italian J Neurol Sci 1986;7(4):453-459 (Pubitemid 16009657)
59. Uemura T, Inoue H, Hirano T. The effects of baclofen on periodic alternating nystagmus and experimentally induced nystagmus. Adv Otorhinolaryngol 1988;42:254-259
60. Troost BT, Janton F, Weaver R. Periodic alternating oscillopsia: a symptom of alternating nystagmus abolished by baclofen. J Clin Neuro Ophthalmol 1990;10(4):273-277
61. Plant GT. Periodic alternating nystagmus in a case of hereditary ataxia and its treatment with baclofen. J Neurol Neurosurg Psychiatry 1982;45(12):1170-1171 (Pubitemid 13166272)
62. Larmande P. Baclofen as a treatment for nystagmus. Ann Neurol 1982;11(2):213
63. Garbutt S, Thakore N, Rucker J, et al. Effects of visual fixation and convergence on periodic alternating nystagmus due to MS. Neuro Ophthalmol 2004;28(5-6):221-229 (Pubitemid 40110534)
64. Jacobs JB, Dell'Osso LF. Congenital nystagmus: hypotheses for its genesis and complex waveforms within a behavioral ocular motor system model. J Vis 2004;4(7):604-625
65. Tarpey P, Thomas S, Sarvananthan N, et al. Mutations in FRMD7, a newly identified member of the FERM family, cause X-linked idiopathic congenital nystagmus. Nat Genet 2006;38(11):1242-1244 •• The recent discovery of the FMRD7 gene for idiopathic infantile nystagmus, which could lead to a better understanding of the mechanism behind nystagmus. (Pubitemid 44646284)
66. Dell'Osso LF, Daroff RB. Congenital nystagmus waveforms and foveation strategy. Doc Ophthalmol 1975;39(1):155-182
67. Abadi RV, Worfolk R. Retinal slip velocities in congenital nystagmus. Vis Res 1989;29(2):195-205 (Pubitemid 19034882)
68. Goldstein HP, Gottlob I, Fendick MG. Visual remapping in infantile nystagmus. Vis Res 1992;32(6):1115-1124
69. Dell'Osso LF, Jacobs JB. An expanded nystagmus acuity function: intra- and intersubject prediction of best-corrected visual acuity. Doc Ophthalmol 2002;104(3):249-276
70. Comer RM, Dawson EL, Lee JP. Baclofen for patients with congenital periodic alternating nystagmus. Strabismus 2006;14(4):205-209 (Pubitemid 44950017)
71. Solomon D, Shepard N, Mishra A. Congenital periodic alternating nystagmus: response to baclofen. Ann NY Acad Sci 2002;956:611-615 (Pubitemid 34457685)
72. Gradstein L, Reinecke RD, Wizov SS, Goldstein HP. Congenital periodic alternating nystagmus. Diagn Manag Ophthalmol 1997;104(6):918-28; discussion 28-29 • A case series addressing the under-diagnosis of congenital periodic alternating nystagmus and possible treatment options.
73. Pradeep A, Thomas S, Roberts EO, et al. Reduction of congenital nystagmus in a patient after smoking cannabis. Strabismus 2008;16(1):29-32 (Pubitemid 351317181)
74. Sarvananthan N, Proudlock FA, Choudhuri I, et al. Pharmacologic treatment of congenital nystagmus. Arch Ophthalmol 2006;124(6):916-918
75. Shery T, Proudlock FA, Sarvananthan N, et al. The effects of gabapentin and memantine in acquired and congenital nystagmus: a retrospective study. Br J Ophthalmol 2006;90(7):839-843 (Pubitemid 43973992)
76. McLean R, Proudlock F, Thomas S, et al. Congenital nystagmus: randomized, controlled, double-masked trial of memantine/gabapentin.[see comment]. Ann Neurol 2007;61(2):130-138 •• The first randomized, controlled trial demonstrating the positive effect of gabapentin and memantine in infantile nystagmus.
77. Nelson LB, Ervin-Mulvey LD, Calhoun JH, et al. Surgical management for abnormal head position in nystagmus: the augmented modified Kestenbaum procedure. Br J Ophthalmol 1984;68(11):796-800
78. Campos EC, Schiavi C, Bellusci C. Surgical management of anomalous head posture because of horizontal gaze palsy or acquired vertical nystagmus.[see comment]. Eye 2003;17(5):587-592
79. von Noorden G, Sprunger D. Large rectus muscle recessions for the treatment of congenital nystagmus. Acta Ophthalmol 1991;109:221-224
80. Atilla H, Erkam N, Isikcelik Y. Surgical treatment in nystagmus. [see comment]. Eye 1999;13(Pt 1):11-15
81. Hertle RW, Dell'Osso LF, FitzGibbon EJ, et al. Horizontal rectus muscle tenotomy in children with infantile nystagmus syndrome: a pilot study. J AAPOS 2004;8(6):539-548 • An alternative surgical approach to treating infantile nystagmus.
82. Wang ZI, Dell'osso LF, Tomsak RL, Jacobs JB. Combining recessions (nystagmus and strabismus) with tenotomy improved visual function and decreased oscillopsia and diplopia in acquired downbeat nystagmus and in horizontal infantile nystagmus syndrome. J AAPOS 2007;11(2):135-141
83. Repka MX, Savino PJ, Reinecke RD. Treatment of acquired nystagmus with botulinum neurotoxin A. Arch Ophthalmol 1994;112(10):1320-1324 (Pubitemid 24320780)
84. Leigh RJ, Tomsak RL, Grant MP, et al. Effectiveness of botulinum toxin administered to abolish acquired nystagmus. Ann Neurol 1992;32(5):633-642
85. Tomsak RL, Remler BF, Averbuch-Heller L, et al. Unsatisfactory treatment of acquired nystagmus with retrobulbar injection of botulinum toxin. Am J Ophthalmol 1995;119(4):489-496
86. Spielmann A. Nystagmus. Curr Opin Ophthalmol 1994;5(5):20-24
87. Barton JJ, Cox TA, Digre KB. Acquired convergence-evoked pendular nystagmus in multiple sclerosis. J Neuro Ophthalmol 1999;19(1):34-38 (Pubitemid 30249282)
88. Abadi RV, Carden D, Simpson J. A new treatment for congenital nystagmus. Br J Ophthalmol 1980;64(1):2-6
89. Jain S, Proudlock F, Constantinescu CS, Gottlob I. Combined pharmacologic and surgical approach to acquired nystagmus due to multiple sclerosis. Am J Ophthalmol 2002;134(5):780-782 • A case report that highlights the combination treatment of acquired nystagmus due to multiple sclerosis with gabapentin and surgery. (Pubitemid 35300408)
90. Kumar A, Thomas S, McLean R, et al. Treatment of acquired periodic alternating nystagmus with memantine - a case report. J Clin Neuropharmacol 2008 In Press • A case report of acquired periodic alternating nystagmus that, although responding to baclofen, was almost abolished when memantine was also prescribed.